Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 9/2018

Open Access 01-09-2018 | Original Article

Prognostic Significance of Post-Operative Morbidity Severity Score After Potentially Curative D2 Gastrectomy for Carcinoma

Authors: Arfon Powell, Alexandra Harriet Coxon, Neil Patel, David Chan, Adam Christian, Wyn Lewis

Published in: Journal of Gastrointestinal Surgery | Issue 9/2018

Login to get access

Abstract

Background

Survival and relapse after gastric cancer surgery are largely attributed to tumor biology and surgical radicality; yet, other prognostic factors have been reported, including respiratory sepsis and anastomotic leakage, but not global morbidity severity score (MSS). The hypothesis tested was that MSS would be associated with both disease-free (DFS) and overall survival (OS).

Methods

Consecutive 373 patients undergoing potentially curative surgery for gastric adenocarcinoma between 2004 and 2016 in a UK cancer network were studied. Complications were defined prospectively as any deviation from a pre-determined post-operative course within 30 days of surgery and classified according to the Clavien-Dindo severity classification (CDSC). Primary outcome measures were DFS and OS.

Results

Post-operative complications were identified in 127 (34.0%) patients, which was associated with 9 (2.4%) post-operative deaths. Five-year DFS and OS were 35.9 and 38.5% for patients with a post-operative complication compared with 59.5 and 61.5% in controls (p < 0.001, p = 0.001, respectively). On multivariable DFS analysis, post-operative morbidity [hazard ratio (HR) 1.63, 95% confidence interval (CI) 1.06–2.50, p = 0.026] was independently associated with poor survival. On multivariable OS analysis, post-operative morbidity HR 2.25 (95% CI 1.04–4.85, p = 0.039) and CDSC HR 1.76 (95% CI 1.35–2.29, p < 0.001) were independently associated with poor survival. These associations were also observed in patients with TNM stage I and II disease with morbidity HR 7.06 (95% CI 1.89–26.38, p = 0.004) and CDSC HR 2.93 (95% CI 1.89–4.55, p < 0.001) offering independent prognostic value.

Conclusion

Post-operative CDSC was an important independent prognostic factor after potentially curative gastrectomy for carcinoma associated with both DFS and OS. Prehabilitation strategies to minimize complications are warranted.
Appendix
Available only for authorised users
Literature
3.
go back to reference Andreou A, Bieb lM, Dadras M, Struecker B, Sauer IM Thuss-Patience PC, Chopra S, Fikatas P, Bahra M, Seehofer D, Pratschke J, Schmidt SC. Anastomotic leak predicts diminished long-term survival after resection for gastric and esophageal cancer. Surgery 2016; 160: 191–203. https://doi.org/10.1016/j.surg.2016.02.020. Andreou A, Bieb lM, Dadras M, Struecker B, Sauer IM Thuss-Patience PC, Chopra S, Fikatas P, Bahra M, Seehofer D, Pratschke J, Schmidt SC. Anastomotic leak predicts diminished long-term survival after resection for gastric and esophageal cancer. Surgery 2016; 160: 191–203. https://​doi.​org/​10.​1016/​j.​surg.​2016.​02.​020.
8.
go back to reference Cunningham D, Allum WH, Stenning SP, Thompson JN, Van deVelde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S Chua YJ, MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11–20.CrossRefPubMed Cunningham D, Allum WH, Stenning SP, Thompson JN, Van deVelde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S Chua YJ, MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11–20.CrossRefPubMed
9.
go back to reference Karran A, Wheat J, Chan D, Blake P, Barlow R, Lewis WG. Propensity Score Analysis of an Enhanced Recovery Programme in Upper Gastrointestinal Cancer Surgery. World J Surg 2016; 40: 1645–54.CrossRefPubMed Karran A, Wheat J, Chan D, Blake P, Barlow R, Lewis WG. Propensity Score Analysis of an Enhanced Recovery Programme in Upper Gastrointestinal Cancer Surgery. World J Surg 2016; 40: 1645–54.CrossRefPubMed
11.
go back to reference Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–13.CrossRefPubMedPubMedCentral
12.
go back to reference Fukuda N, Wada J, Niki M, Sugiyama Y, Mushiake H. Factors predicting mortality in emergency abdominal surgery in the elderly. World J Emerg Surg 2012; 7:12.CrossRefPubMedPubMedCentral Fukuda N, Wada J, Niki M, Sugiyama Y, Mushiake H. Factors predicting mortality in emergency abdominal surgery in the elderly. World J Emerg Surg 2012; 7:12.CrossRefPubMedPubMedCentral
14.
go back to reference Zhang WH, Chen XZ, Yang K, Liu K, Guo DJ, Wang W, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Risk Factors and Survival Outcomes for Postoperative Pulmonary Complications in Gastric Cancer Patients. Hepatogastroenterology 2015; 62: 766–72.PubMed Zhang WH, Chen XZ, Yang K, Liu K, Guo DJ, Wang W, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Risk Factors and Survival Outcomes for Postoperative Pulmonary Complications in Gastric Cancer Patients. Hepatogastroenterology 2015; 62: 766–72.PubMed
16.
go back to reference Powell AG, Parkinson D, Pate lN, Christian A, Lewis WG. Prognostic significance of serum inflammatory markers in gastric cancer. J Gastrointest Surg. 2017 [In Press]. Powell AG, Parkinson D, Pate lN, Christian A, Lewis WG. Prognostic significance of serum inflammatory markers in gastric cancer. J Gastrointest Surg. 2017 [In Press].
17.
go back to reference Barberan-Garcia A, UbréM, Roca J, Lacy AM, Burgos F, Risco R, Momblán D, Balust J, Blanco I, Martínez-Pallí G. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg 2017; May 9. https://doi.org/10.1097/SLA.0000000000002293. Barberan-Garcia A, UbréM, Roca J, Lacy AM, Burgos F, Risco R, Momblán D, Balust J, Blanco I, Martínez-Pallí G. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg 2017; May 9. https://​doi.​org/​10.​1097/​SLA.​0000000000002293​.​
20.
go back to reference Nelen SD, Heuthorst L, Verhoeven RHA, Polat F, Kruyt PM, Reijnders K, Ferenschild FTJ, Bonenkamp JJ, Rutter JE, deWilt JHW, Spillenaar Bilgen EJ. Impact of Centralizing Gastric Cancer Surgery on Treatment, Morbidity, and Mortality. J Gastrointest Surg 2017 Aug 16. https://doi.org/10.1007/s11605-017-3531-x. Nelen SD, Heuthorst L, Verhoeven RHA, Polat F, Kruyt PM, Reijnders K, Ferenschild FTJ, Bonenkamp JJ, Rutter JE, deWilt JHW, Spillenaar Bilgen EJ. Impact of Centralizing Gastric Cancer Surgery on Treatment, Morbidity, and Mortality. J Gastrointest Surg 2017 Aug 16. https://​doi.​org/​10.​1007/​s11605-017-3531-x.​
21.
Metadata
Title
Prognostic Significance of Post-Operative Morbidity Severity Score After Potentially Curative D2 Gastrectomy for Carcinoma
Authors
Arfon Powell
Alexandra Harriet Coxon
Neil Patel
David Chan
Adam Christian
Wyn Lewis
Publication date
01-09-2018
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 9/2018
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-3787-9

Other articles of this Issue 9/2018

Journal of Gastrointestinal Surgery 9/2018 Go to the issue